AstraZeneca stock gains 1.22 percent at the close
Published on 09/22/2026 at 23:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
AstraZeneca stock closed at USD 168.10 on the Nasdaq on September 22, 2026, up 1.22 percent from the prior close. The move lagged the S&P 500, which gained 1.49 percent on the same session.
September 22, 2026 in numbers
AstraZeneca plc (ISIN GB0009895292) opened at USD 168.15 and traded within a 12-month range of USD 145.79 to USD 212.71 on the Nasdaq on September 22, 2026. The close was USD 44.61 below the 12-month high and USD 22.31 above the low. Zacks reported that the stock lagged the broader market during the session.
In London, AstraZeneca shares closed 0.59 percent higher at 11:35 a.m. ET on September 22, 2026. The U.S. move was stronger than the home-market percentage, reflecting the exchange rate. A September 22 report said Deutsche Bank raised its target, while Reuters described renewed investor scrutiny of large-pharmaceutical merger strategies.
Third-quarter results on October 30, 2026
AstraZeneca is expected to present its third-quarter 2026 results on October 30, 2026, according to finanzen.ch. The result date is the next company-specific event identified for the U.S.-listed security.
